vs

Side-by-side financial comparison of CABOT CORP (CBT) and Sensata Technologies Holding plc (ST). Click either name above to swap in a different company.

Sensata Technologies Holding plc is the larger business by last-quarter revenue ($934.8M vs $849.0M, roughly 1.1× CABOT CORP). Sensata Technologies Holding plc runs the higher net margin — 9.3% vs 8.6%, a 0.7% gap on every dollar of revenue. On growth, Sensata Technologies Holding plc posted the faster year-over-year revenue change (2.6% vs -11.1%). Sensata Technologies Holding plc produced more free cash flow last quarter ($104.6M vs $57.0M). Over the past eight quarters, Sensata Technologies Holding plc's revenue compounded faster (-5.0% CAGR vs -8.7%).

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

Sensata Technologies Holding plc is a global industrial technology company that designs, manufactures and sells a broad portfolio of sensing, electrical protection and control solutions. Its products serve automotive, industrial, aerospace, HVAC, telecommunications and heavy vehicle end markets, catering to manufacturing and enterprise clients across the world.

CBT vs ST — Head-to-Head

Bigger by revenue
ST
ST
1.1× larger
ST
$934.8M
$849.0M
CBT
Growing faster (revenue YoY)
ST
ST
+13.7% gap
ST
2.6%
-11.1%
CBT
Higher net margin
ST
ST
0.7% more per $
ST
9.3%
8.6%
CBT
More free cash flow
ST
ST
$47.6M more FCF
ST
$104.6M
$57.0M
CBT
Faster 2-yr revenue CAGR
ST
ST
Annualised
ST
-5.0%
-8.7%
CBT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CBT
CBT
ST
ST
Revenue
$849.0M
$934.8M
Net Profit
$73.0M
$87.1M
Gross Margin
24.9%
30.6%
Operating Margin
15.2%
15.1%
Net Margin
8.6%
9.3%
Revenue YoY
-11.1%
2.6%
Net Profit YoY
-21.5%
24.6%
EPS (diluted)
$1.37
$0.59

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBT
CBT
ST
ST
Q1 26
$934.8M
Q4 25
$849.0M
$917.9M
Q3 25
$899.0M
$932.0M
Q2 25
$923.0M
$943.4M
Q1 25
$936.0M
$911.3M
Q4 24
$955.0M
$907.7M
Q3 24
$1.0B
$982.8M
Q2 24
$1.0B
$1.0B
Net Profit
CBT
CBT
ST
ST
Q1 26
$87.1M
Q4 25
$73.0M
$63.2M
Q3 25
$43.0M
$-162.5M
Q2 25
$101.0M
$60.7M
Q1 25
$94.0M
$69.9M
Q4 24
$93.0M
$5.8M
Q3 24
$137.0M
$-25.0M
Q2 24
$109.0M
$71.7M
Gross Margin
CBT
CBT
ST
ST
Q1 26
30.6%
Q4 25
24.9%
29.0%
Q3 25
24.5%
27.8%
Q2 25
26.4%
30.3%
Q1 25
25.7%
29.9%
Q4 24
24.6%
27.1%
Q3 24
24.0%
28.6%
Q2 24
25.2%
30.0%
Operating Margin
CBT
CBT
ST
ST
Q1 26
15.1%
Q4 25
15.2%
10.9%
Q3 25
15.2%
-13.2%
Q2 25
18.1%
14.6%
Q1 25
17.3%
13.4%
Q4 24
16.2%
8.1%
Q3 24
15.0%
-20.3%
Q2 24
16.9%
12.5%
Net Margin
CBT
CBT
ST
ST
Q1 26
9.3%
Q4 25
8.6%
6.9%
Q3 25
4.8%
-17.4%
Q2 25
10.9%
6.4%
Q1 25
10.0%
7.7%
Q4 24
9.7%
0.6%
Q3 24
13.7%
-2.5%
Q2 24
10.7%
6.9%
EPS (diluted)
CBT
CBT
ST
ST
Q1 26
$0.59
Q4 25
$1.37
$0.45
Q3 25
$0.80
$-1.12
Q2 25
$1.86
$0.41
Q1 25
$1.69
$0.47
Q4 24
$1.67
$0.05
Q3 24
$2.41
$-0.17
Q2 24
$1.94
$0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBT
CBT
ST
ST
Cash + ST InvestmentsLiquidity on hand
$230.0M
$635.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.6B
$2.9B
Total Assets
$3.8B
$6.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBT
CBT
ST
ST
Q1 26
$635.1M
Q4 25
$230.0M
$573.0M
Q3 25
$258.0M
$791.3M
Q2 25
$239.0M
$661.8M
Q1 25
$213.0M
$588.1M
Q4 24
$183.0M
$593.7M
Q3 24
$223.0M
$506.2M
Q2 24
$197.0M
$1.0B
Total Debt
CBT
CBT
ST
ST
Q1 26
Q4 25
$2.8B
Q3 25
$1.1B
Q2 25
Q1 25
Q4 24
$3.2B
Q3 24
$1.1B
Q2 24
Stockholders' Equity
CBT
CBT
ST
ST
Q1 26
$2.9B
Q4 25
$1.6B
$2.8B
Q3 25
$1.6B
$2.7B
Q2 25
$1.5B
$2.9B
Q1 25
$1.4B
$2.8B
Q4 24
$1.4B
$2.9B
Q3 24
$1.4B
$3.0B
Q2 24
$1.3B
$3.0B
Total Assets
CBT
CBT
ST
ST
Q1 26
$6.8B
Q4 25
$3.8B
$6.8B
Q3 25
$3.8B
$7.1B
Q2 25
$3.8B
$7.3B
Q1 25
$3.8B
$7.2B
Q4 24
$3.6B
$7.1B
Q3 24
$3.7B
$7.3B
Q2 24
$3.6B
$8.2B
Debt / Equity
CBT
CBT
ST
ST
Q1 26
Q4 25
1.02×
Q3 25
0.70×
Q2 25
Q1 25
Q4 24
1.11×
Q3 24
0.75×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBT
CBT
ST
ST
Operating Cash FlowLast quarter
$126.0M
$122.5M
Free Cash FlowOCF − Capex
$57.0M
$104.6M
FCF MarginFCF / Revenue
6.7%
11.2%
Capex IntensityCapex / Revenue
8.1%
Cash ConversionOCF / Net Profit
1.73×
1.41×
TTM Free Cash FlowTrailing 4 quarters
$401.0M
$508.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBT
CBT
ST
ST
Q1 26
$122.5M
Q4 25
$126.0M
$201.5M
Q3 25
$219.0M
$159.9M
Q2 25
$249.0M
$140.9M
Q1 25
$73.0M
$119.2M
Q4 24
$124.0M
$170.7M
Q3 24
$204.0M
$130.9M
Q2 24
$207.0M
$143.5M
Free Cash Flow
CBT
CBT
ST
ST
Q1 26
$104.6M
Q4 25
$57.0M
$151.9M
Q3 25
$155.0M
$136.2M
Q2 25
$188.0M
$115.5M
Q1 25
$1.0M
$86.6M
Q4 24
$47.0M
$138.9M
Q3 24
$112.0M
$91.3M
Q2 24
$155.0M
$98.4M
FCF Margin
CBT
CBT
ST
ST
Q1 26
11.2%
Q4 25
6.7%
16.6%
Q3 25
17.2%
14.6%
Q2 25
20.4%
12.2%
Q1 25
0.1%
9.5%
Q4 24
4.9%
15.3%
Q3 24
11.2%
9.3%
Q2 24
15.3%
9.5%
Capex Intensity
CBT
CBT
ST
ST
Q1 26
Q4 25
8.1%
5.4%
Q3 25
7.1%
2.5%
Q2 25
6.6%
2.7%
Q1 25
7.7%
3.6%
Q4 24
8.1%
3.5%
Q3 24
9.2%
4.0%
Q2 24
5.1%
4.4%
Cash Conversion
CBT
CBT
ST
ST
Q1 26
1.41×
Q4 25
1.73×
3.19×
Q3 25
5.09×
Q2 25
2.47×
2.32×
Q1 25
0.78×
1.70×
Q4 24
1.33×
29.50×
Q3 24
1.49×
Q2 24
1.90×
2.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

ST
ST

Segment breakdown not available.

Related Comparisons